These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 31917237)

  • 21. Clusterin contributes to hepatitis C virus-related hepatocellular carcinoma by regulating autophagy.
    Fu N; Du H; Li D; Lu Y; Li W; Wang Y; Kong L; Du J; Zhao S; Ren W; Han F; Wang R; Zhang Y; Nan Y
    Life Sci; 2020 Sep; 256():117911. PubMed ID: 32504756
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Green tea phenolic epicatechins inhibit hepatitis C virus replication via cycloxygenase-2 and attenuate virus-induced inflammation.
    Lin YT; Wu YH; Tseng CK; Lin CK; Chen WC; Hsu YC; Lee JC
    PLoS One; 2013; 8(1):e54466. PubMed ID: 23365670
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fluvastatin interferes with hepatitis C virus replication via microtubule bundling and a doublecortin-like kinase-mediated mechanism.
    Ali N; Allam H; Bader T; May R; Basalingappa KM; Berry WL; Chandrakesan P; Qu D; Weygant N; Bronze MS; Umar S; Janknecht R; Sureban SM; Huycke M; Houchen CW
    PLoS One; 2013; 8(11):e80304. PubMed ID: 24260365
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FUSE Binding Protein 1 Facilitates Persistent Hepatitis C Virus Replication in Hepatoma Cells by Regulating Tumor Suppressor p53.
    Dixit U; Pandey AK; Liu Z; Kumar S; Neiditch MB; Klein KM; Pandey VN
    J Virol; 2015 Aug; 89(15):7905-21. PubMed ID: 25995247
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Inhibition of hepatitis C virus replication by mycophenolic acid in hepatocytes].
    Chen H; Ye L; Su JM; Li Y; Zeng JR; Huo WZ
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2013 Feb; 27(1):35-8. PubMed ID: 23855126
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-hepatitis C virus activity and synergistic effect of Nymphaea alba extracts and bioactive constituents in liver infected cells.
    Rehman S; Ashfaq UA; Ijaz B; Riazuddin S
    Microb Pathog; 2018 Aug; 121():198-209. PubMed ID: 29775725
    [TBL] [Abstract][Full Text] [Related]  

  • 27. S-adenosyl-L-methionine modifies antioxidant-enzymes, glutathione-biosynthesis and methionine adenosyltransferases-1/2 in hepatitis C virus-expressing cells.
    Lozano-Sepulveda SA; Bautista-Osorio E; Merino-Mascorro JA; Varela-Rey M; Muñoz-Espinosa LE; Cordero-Perez P; Martinez-Chantar ML; Rivas-Estilla AM
    World J Gastroenterol; 2016 Apr; 22(14):3746-57. PubMed ID: 27076759
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro infection of immortalized primary hepatocytes by HCV genotype 4a and inhibition of virus replication by cyclosporin.
    El-Farrash MA; Aly HH; Watashi K; Hijikata M; Egawa H; Shimotohno K
    Microbiol Immunol; 2007; 51(1):127-33. PubMed ID: 17237608
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Simvastatin and metformin inhibit cell growth in hepatitis C virus infected cells via mTOR increasing PTEN and autophagy.
    Del Campo JA; García-Valdecasas M; Gil-Gómez A; Rojas Á; Gallego P; Ampuero J; Gallego-Durán R; Pastor H; Grande L; Padillo FJ; Muntané J; Romero-Gómez M
    PLoS One; 2018; 13(1):e0191805. PubMed ID: 29385181
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Soraphen A: A broad-spectrum antiviral natural product with potent anti-hepatitis C virus activity.
    Koutsoudakis G; Romero-Brey I; Berger C; Pérez-Vilaró G; Monteiro Perin P; Vondran FW; Kalesse M; Harmrolfs K; Müller R; Martinez JP; Pietschmann T; Bartenschlager R; Brönstrup M; Meyerhans A; Díez J
    J Hepatol; 2015 Oct; 63(4):813-21. PubMed ID: 26070407
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA expression profiling in HCV-infected human hepatoma cells identifies potential anti-viral targets induced by interferon-α.
    Zhang X; Daucher M; Armistead D; Russell R; Kottilil S
    PLoS One; 2013; 8(2):e55733. PubMed ID: 23418453
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Double-stranded RNA-activated protein kinase inhibits hepatitis C virus replication but may be not essential in interferon treatment.
    Chang JH; Kato N; Muroyama R; Taniguchi H; Guleng B; Dharel N; Shao RX; Tateishi K; Jazag A; Kawabe T; Omata M
    Liver Int; 2010 Feb; 30(2):311-8. PubMed ID: 19840259
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of Quercetin on Hepatitis C Virus Life Cycle: From Viral to Host Targets.
    Rojas Á; Del Campo JA; Clement S; Lemasson M; García-Valdecasas M; Gil-Gómez A; Ranchal I; Bartosch B; Bautista JD; Rosenberg AR; Negro F; Romero-Gómez M
    Sci Rep; 2016 Aug; 6():31777. PubMed ID: 27546480
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of hepatitis C virus RNA translation by antisense bile acid conjugated phosphorothioate modified oligodeoxynucleotides (ODN).
    González-Carmona MA; Quasdorff M; Vogt A; Tamke A; Yildiz Y; Hoffmann P; Lehmann T; Bartenschlager R; Engels JW; Kullak-Ublick GA; Sauerbruch T; Caselmann WH
    Antiviral Res; 2013 Jan; 97(1):49-59. PubMed ID: 23142319
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vitamin D: an innate antiviral agent suppressing hepatitis C virus in human hepatocytes.
    Gal-Tanamy M; Bachmetov L; Ravid A; Koren R; Erman A; Tur-Kaspa R; Zemel R
    Hepatology; 2011 Nov; 54(5):1570-9. PubMed ID: 21793032
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Up-regulation of Hedgehog pathway is associated with cellular permissiveness for hepatitis C virus replication.
    Choi SS; Bradrick S; Qiang G; Mostafavi A; Chaturvedi G; Weinman SA; Diehl AM; Jhaveri R
    Hepatology; 2011 Nov; 54(5):1580-90. PubMed ID: 21793033
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fungus-Derived Neoechinulin B as a Novel Antagonist of Liver X Receptor, Identified by Chemical Genetics Using a Hepatitis C Virus Cell Culture System.
    Nakajima S; Watashi K; Ohashi H; Kamisuki S; Izaguirre-Carbonell J; Kwon AT; Suzuki H; Kataoka M; Tsukuda S; Okada M; Moi ML; Takeuchi T; Arita M; Suzuki R; Aizaki H; Kato T; Suzuki T; Hasegawa H; Takasaki T; Sugawara F; Wakita T
    J Virol; 2016 Oct; 90(20):9058-74. PubMed ID: 27489280
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of ethanol on innate antiviral pathways and HCV replication in human liver cells.
    Plumlee CR; Lazaro CA; Fausto N; Polyak SJ
    Virol J; 2005 Dec; 2():89. PubMed ID: 16324217
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tannic Acid Inhibits Hepatitis C Virus Entry into Huh7.5 Cells.
    Liu S; Chen R; Hagedorn CH
    PLoS One; 2015; 10(7):e0131358. PubMed ID: 26186636
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Infection with hepatitis C virus depends on TACSTD2, a regulator of claudin-1 and occludin highly downregulated in hepatocellular carcinoma.
    Sekhar V; Pollicino T; Diaz G; Engle RE; Alayli F; Melis M; Kabat J; Tice A; Pomerenke A; Altan-Bonnet N; Zamboni F; Lusso P; Emerson SU; Farci P
    PLoS Pathog; 2018 Mar; 14(3):e1006916. PubMed ID: 29538454
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.